{"pmid":32205856,"title":"COVID-19 infection: the perspectives on immune responses.","text":["COVID-19 infection: the perspectives on immune responses.","Cell Death Differ","Shi, Yufang","Wang, Ying","Shao, Changshun","Huang, Jianan","Gan, Jianhe","Huang, Xiaoping","Bucci, Enrico","Piacentini, Mauro","Ippolito, Giuseppe","Melino, Gerry","32205856"],"journal":"Cell Death Differ","authors":["Shi, Yufang","Wang, Ying","Shao, Changshun","Huang, Jianan","Gan, Jianhe","Huang, Xiaoping","Bucci, Enrico","Piacentini, Mauro","Ippolito, Giuseppe","Melino, Gerry"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32205856","week":"202013|Mar 23 - Mar 29","doi":"10.1038/s41418-020-0530-3","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1662177578750836736,"score":7.055025,"similar":[{"pmid":31981224,"title":"Coronavirus infections and immune responses.","text":["Coronavirus infections and immune responses.","Coronaviruses (CoVs) are by far the largest group of known positive-sense RNA viruses having an extensive range of natural hosts. In the past few decades, newly evolved Coronaviruses have posed a global threat to public health. The immune response is essential to control and eliminate CoV infections, however, maladjusted immune responses may result in immunopathology and impaired pulmonary gas exchange. Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs. In this review, we provide an update on CoV infections and relevant diseases, particularly the host defense against CoV-induced inflammation of lung tissue, as well as the role of the innate immune system in the pathogenesis and clinical treatment.","J Med Virol","Li, Geng","Fan, Yaohua","Lai, Yanni","Han, Tiantian","Li, Zonghui","Zhou, Peiwen","Pan, Pan","Wang, Wenbiao","Hu, Dingwen","Liu, Xiaohong","Zhang, Qiwei","Wu, Jianguo","31981224"],"abstract":["Coronaviruses (CoVs) are by far the largest group of known positive-sense RNA viruses having an extensive range of natural hosts. In the past few decades, newly evolved Coronaviruses have posed a global threat to public health. The immune response is essential to control and eliminate CoV infections, however, maladjusted immune responses may result in immunopathology and impaired pulmonary gas exchange. Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs. In this review, we provide an update on CoV infections and relevant diseases, particularly the host defense against CoV-induced inflammation of lung tissue, as well as the role of the innate immune system in the pathogenesis and clinical treatment."],"journal":"J Med Virol","authors":["Li, Geng","Fan, Yaohua","Lai, Yanni","Han, Tiantian","Li, Zonghui","Zhou, Peiwen","Pan, Pan","Wang, Wenbiao","Hu, Dingwen","Liu, Xiaohong","Zhang, Qiwei","Wu, Jianguo"],"date":"2020-01-26T11:00:00Z","year":2020,"_id":"31981224","week":"20204|Jan 20 - Jan 26","doi":"10.1002/jmv.25685","keywords":["chemokine","coronavirus","cytokines","inflammation","interferon"],"source":"PubMed","locations":["CoVs","Coronaviruses"],"topics":["Transmission","Mechanism","Treatment"],"weight":1,"_version_":1661359647567642624,"score":63.688972},{"pmid":32105090,"title":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.","text":["Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.","As the world is witnessing the epidemic of COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path to those of SARS and MERS. The rapid genomic sequencing and open access data, together with advanced vaccine technology, are expected to give us more knowledge on the pathogen itself, including the host immune response as well as the plan for therapeutic vaccines in the near future. This review aims to provide a comparative view among SARS-CoV, MERS-CoV and the newly epidemic SARS-CoV-2, in the hope to gain a better understanding of the host-pathogen interaction, host immune responses, and the pathogen immune evasion strategies. This predictive view may help in designing an immune intervention or preventive vaccine for COVID-19 in the near future.","Asian Pac J Allergy Immunol","Prompetchara, Eakachai","Ketloy, Chutitorn","Palaga, Tanapat","32105090"],"abstract":["As the world is witnessing the epidemic of COVID-19, a disease caused by a novel coronavirus, SARS-CoV-2, emerging genetics and clinical evidences suggest a similar path to those of SARS and MERS. The rapid genomic sequencing and open access data, together with advanced vaccine technology, are expected to give us more knowledge on the pathogen itself, including the host immune response as well as the plan for therapeutic vaccines in the near future. This review aims to provide a comparative view among SARS-CoV, MERS-CoV and the newly epidemic SARS-CoV-2, in the hope to gain a better understanding of the host-pathogen interaction, host immune responses, and the pathogen immune evasion strategies. This predictive view may help in designing an immune intervention or preventive vaccine for COVID-19 in the near future."],"journal":"Asian Pac J Allergy Immunol","authors":["Prompetchara, Eakachai","Ketloy, Chutitorn","Palaga, Tanapat"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32105090","week":"20209|Feb 24 - Mar 01","doi":"10.12932/AP-200220-0772","source":"PubMed","topics":["Mechanism","Treatment"],"weight":1,"_version_":1661359647545622529,"score":48.644127}]}